1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Marx, U.C.
Roesch, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
270
15194
15202
10.1074/jbc.270.25.15194
7797503
Structure of human parathyroid hormone 1-37 in solution.
1995
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4409.144
HUMAN PARATHYROID HORMONE FRAGMENT 1 - 37
1
man
polymer
no
no
SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL
SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVAL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
repository
Initial release
Version format compliance
Version format compliance
Database references
1
0
1995-07-10
1
1
2008-03-24
1
2
2011-07-13
1
3
2012-02-22
Y
1995-02-14
REL
10
BRUNGER
refinement
X-PLOR
SER
1
n
1
SER
1
A
VAL
2
n
2
VAL
2
A
SER
3
n
3
SER
3
A
GLU
4
n
4
GLU
4
A
ILE
5
n
5
ILE
5
A
GLN
6
n
6
GLN
6
A
LEU
7
n
7
LEU
7
A
MET
8
n
8
MET
8
A
HIS
9
n
9
HIS
9
A
ASN
10
n
10
ASN
10
A
LEU
11
n
11
LEU
11
A
GLY
12
n
12
GLY
12
A
LYS
13
n
13
LYS
13
A
HIS
14
n
14
HIS
14
A
LEU
15
n
15
LEU
15
A
ASN
16
n
16
ASN
16
A
SER
17
n
17
SER
17
A
MET
18
n
18
MET
18
A
GLU
19
n
19
GLU
19
A
ARG
20
n
20
ARG
20
A
VAL
21
n
21
VAL
21
A
GLU
22
n
22
GLU
22
A
TRP
23
n
23
TRP
23
A
LEU
24
n
24
LEU
24
A
ARG
25
n
25
ARG
25
A
LYS
26
n
26
LYS
26
A
LYS
27
n
27
LYS
27
A
LEU
28
n
28
LEU
28
A
GLN
29
n
29
GLN
29
A
ASP
30
n
30
ASP
30
A
VAL
31
n
31
VAL
31
A
HIS
32
n
32
HIS
32
A
ASN
33
n
33
ASN
33
A
PHE
34
n
34
PHE
34
A
VAL
35
n
35
VAL
35
A
ALA
36
n
36
ALA
36
A
LEU
37
n
37
LEU
37
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
4
A
A
O
H
TRP
LYS
23
27
1.60
1
A
ARG
20
0.264
SIDE CHAIN
1
A
ARG
25
0.317
SIDE CHAIN
2
A
ARG
20
0.315
SIDE CHAIN
2
A
ARG
25
0.313
SIDE CHAIN
3
A
ARG
20
0.297
SIDE CHAIN
3
A
ARG
25
0.309
SIDE CHAIN
4
A
ARG
20
0.315
SIDE CHAIN
4
A
ARG
25
0.312
SIDE CHAIN
5
A
ARG
20
0.307
SIDE CHAIN
5
A
ARG
25
0.312
SIDE CHAIN
6
A
ARG
20
0.316
SIDE CHAIN
6
A
ARG
25
0.314
SIDE CHAIN
7
A
ARG
20
0.294
SIDE CHAIN
7
A
ARG
25
0.317
SIDE CHAIN
8
A
ARG
20
0.301
SIDE CHAIN
8
A
ARG
25
0.312
SIDE CHAIN
9
A
ARG
20
0.300
SIDE CHAIN
9
A
ARG
25
0.313
SIDE CHAIN
10
A
ARG
20
0.315
SIDE CHAIN
10
A
ARG
25
0.311
SIDE CHAIN
1
A
GLU
4
-97.91
37.51
1
A
GLN
6
-67.45
74.08
1
A
LEU
7
74.30
45.31
1
A
ASN
10
23.76
62.49
1
A
ASN
16
-101.34
-162.30
1
A
GLN
29
-98.46
49.78
1
A
ASP
30
-155.94
-43.61
1
A
ASN
33
-164.21
-49.30
2
A
VAL
2
71.14
139.39
2
A
GLU
4
-102.46
44.05
2
A
ILE
5
-153.68
68.67
2
A
MET
18
84.27
-51.98
2
A
ASP
30
-142.19
19.66
2
A
VAL
31
-137.77
-57.07
2
A
PHE
34
-69.08
98.75
3
A
VAL
2
67.25
160.09
3
A
SER
3
-171.01
115.59
3
A
GLU
4
-157.15
37.83
3
A
LEU
11
67.34
-165.01
3
A
LYS
13
59.79
17.99
3
A
HIS
14
164.15
125.85
3
A
MET
18
86.25
-51.12
3
A
ALA
36
-104.38
45.21
4
A
VAL
2
51.11
-173.67
4
A
GLU
4
-107.62
53.27
4
A
ASN
10
-98.92
52.92
4
A
MET
18
84.20
-38.48
5
A
LEU
11
85.46
15.60
5
A
LYS
13
57.46
83.02
5
A
PHE
34
58.77
70.03
6
A
SER
3
59.14
83.33
6
A
LEU
11
-125.93
-144.81
6
A
HIS
14
-163.97
90.42
6
A
ASN
33
59.64
88.36
6
A
ALA
36
-102.97
-140.86
7
A
SER
3
-150.22
31.86
7
A
HIS
14
68.99
116.00
7
A
ASN
16
-134.59
-83.90
7
A
SER
17
-147.46
-67.78
7
A
LYS
26
-98.00
-89.41
7
A
LEU
28
60.11
60.75
7
A
PHE
34
68.90
102.45
7
A
ALA
36
-132.65
-150.34
8
A
GLN
29
-115.01
53.91
8
A
ASP
30
-151.15
-61.01
8
A
HIS
32
72.89
-68.63
8
A
ALA
36
-158.10
-149.32
9
A
SER
3
63.48
91.14
9
A
ILE
5
-147.53
26.77
9
A
LYS
13
70.40
116.22
10
A
VAL
2
71.05
133.32
10
A
GLU
4
-150.42
36.98
10
A
LEU
15
51.65
-161.35
10
A
ASN
16
-146.68
-76.07
10
A
SER
17
-134.46
-86.24
10
A
GLN
29
-96.74
30.21
10
A
ASP
30
-144.33
19.07
10
A
ALA
36
-145.27
-150.12
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
HUMAN PARATHYROID HORMONE FRAGMENT 1 - 37 (HPTH(1-37)) (NMR, 10 STRUCTURES)
STRUCTURE OF HUMAN PARATHYROID HORMONE 1-37 IN SOLUTION
1
Y
N
A
GLN
6
A
GLN
6
HELX_P
A
HIS
9
A
HIS
9
1
H1
4
A
SER
17
A
SER
17
HELX_P
A
LEU
28
A
LEU
28
1
H2
12
HORMONE
HORMONE
PTHY_HUMAN
UNP
1
1
P01270
MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ
RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ
32
68
1HPH
1
37
P01270
A
1
1
37
1
P 1